Merck & Co., Inc. Logo

Merck & Co., Inc.

A global biopharma developing innovative medicines, vaccines, and animal health products.

MRK | F

Overview

Corporate Details

ISIN(s):
DE0006599905 (+71 more)
LEI:
4YV9Y5M8S0BRK1RP0397
Country:
United States of America
Address:
126 EAST LINCOLN AVENUE, 7065 RAHWAY
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Merck & Co., Inc. is a global, research-intensive biopharmaceutical company dedicated to developing innovative health solutions. With a history spanning over 130 years, the company discovers, develops, manufactures, and markets a broad range of products, including prescription medicines, vaccines, biologic therapies, and animal health products. Merck focuses on scientific innovation to address significant global health challenges, leveraging a robust research pipeline and extensive clinical trials. The company is a leader in various therapeutic areas, particularly oncology and vaccines, aiming to save and improve lives worldwide.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-28 14:26
Declaration of Voting Results & Voting Rights Announcements
English 80.9 KB
2025-11-24 10:50
Declaration of Voting Results & Voting Rights Announcements
English 78.5 KB
2025-11-20 14:25
Declaration of Voting Results & Voting Rights Announcements
English 78.5 KB
2025-11-17 00:00
Regulatory News Service
Q3 statement / Q3 financial report 2025
English 489.3 KB
2025-10-24 15:20
Declaration of Voting Results & Voting Rights Announcements
English 78.0 KB
2025-10-23 17:37
Declaration of Voting Results & Voting Rights Announcements
English 78.0 KB
2025-10-21 09:10
Declaration of Voting Results & Voting Rights Announcements
English 78.0 KB
2025-10-17 18:51
Declaration of Voting Results & Voting Rights Announcements
English 78.0 KB
2025-10-16 09:03
Declaration of Voting Results & Voting Rights Announcements
English 77.8 KB
2025-10-14 08:31
Declaration of Voting Results & Voting Rights Announcements
English 77.8 KB
2025-09-01 00:00
Interim Report
Half-yearly financial report 2025
English 999.9 KB
2025-08-13 17:39
Declaration of Voting Results & Voting Rights Announcements
English 81.2 KB
2025-08-05 23:02
Declaration of Voting Results & Voting Rights Announcements
English 81.2 KB
2025-07-14 15:01
Declaration of Voting Results & Voting Rights Announcements
English 81.2 KB
2025-07-08 18:21
Declaration of Voting Results & Voting Rights Announcements
English 81.2 KB

Automate Your Workflow. Get a real-time feed of all Merck & Co., Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Merck & Co., Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Merck & Co., Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France
ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden
ABLI
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapies for oncology & ophthalmology.
United States of America
ABP
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France
AB
ACADIA PHARMACEUTICALS INC Logo
Develops and commercializes innovative therapies for CNS disorders and rare diseases.
United States of America
ACAD
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
Developing cytisinicline, a plant-based treatment for smoking cessation and nicotine addiction.
United States of America
ACHV
AC Immune SA Logo
Developing precision medicine to diagnose, treat, and prevent neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
A clinical-stage biopharma developing novel drugs for immuno-inflammatory diseases.
United States of America
ACRS
Actinium Pharmaceuticals, Inc. Logo
Develops targeted radiotherapies for advanced cancers like AML and prostate cancer.
United States of America
ATNM

Talk to a Data Expert

Have a question? We'll get back to you promptly.